.gif)
| Cas No.: | 1639792-20-3 |
| SMILES: | CCO1[C@H](C([O-][Mg]12[O-]C([C@@H](O2CC)CC3=CC=C(OCCN4C(C)=CC=C4C5=CC=C(SC)C=C5)C=C3)=O)=O)CC6=CC=C(OCCN7C(C)=CC=C7C8=CC=C(SC)C=C8)C=C6.[MgH+] |
| Formula: | C25H28NO4S.1/2Mg |
| M.Wt: | 450.71 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| Description: | In db/db mice, 12-day treatment with Saroglitazar (0.01-3 mg/kg per day, orally) causes dose-dependent reductions in serum triglycerides (TG), free fatty acids (FFA), and glucose. The ED50 for these effects is found to be 0.05, 0.19, and 0.19 mg/kg, respe |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|